Literature DB >> 11845013

Why do patients with chronic musculoskeletal disorders consult their primary care physicians?

Till Uhlig1, Kåre Birger Hagen, Tore Kristian Kvien.   

Abstract

Symptoms are a daily occurrence in the lives of most people, and many do not consult their doctors for their clinical complaints. Information on the frequency of musculoskeletal disorders and on healthcare utilization patterns can be obtained from population surveys or from records of visits to primary care physicians. A decision to consult a primary care physician for musculoskeletal disorders is not based simply on the presence or absence of physical symptoms, but also involves a complex mixture of social and psychological factors.

Entities:  

Mesh:

Year:  2002        PMID: 11845013     DOI: 10.1097/00002281-200203000-00005

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  4 in total

1.  Competency based clinical shoulder examination training improves physical exam, confidence, and knowledge in common shoulder conditions.

Authors:  Michal Kalli Hose; John Fontanesi; Manjulika Woytowitz; Diego Jarrin; Anna Quan
Journal:  J Gen Intern Med       Date:  2017-08-07       Impact factor: 5.128

2.  Chronic pain in primary care. German figures from 1991 and 2006.

Authors:  Christine H Friessem; Anne Willweber-Strumpf; Michael W Zenz
Journal:  BMC Public Health       Date:  2009-08-18       Impact factor: 3.295

3.  Parental chronic pain in relation to chronic pain in their adult offspring: family-linkage within the HUNT Study, Norway.

Authors:  Ragnhild Lier; Tom Ivar Lund Nilsen; Paul Jarle Mork
Journal:  BMC Public Health       Date:  2014-08-05       Impact factor: 3.295

4.  "Somebody to say 'come on we can sort this'": a qualitative study of primary care consultation among older adults with symptomatic foot osteoarthritis.

Authors:  Martin J Thomas; Andrew Moore; Edward Roddy; George Peat
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-12       Impact factor: 4.794

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.